Company Filing History:
Years Active: 2020-2024
Title: Christy Ann Thomson: Innovator in Immunology
Introduction
Christy Ann Thomson is a prominent inventor based in Port Moody, Canada. She has made significant contributions to the field of immunology, particularly in the development of innovative therapies that enhance the function of T-regulatory cells. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Thomson's latest patents focus on Interleukin-2 muteins for the expansion of T-regulatory cells. These patents detail the development of IL-2 muteins, IL-2 mutein Fc-fusion molecules, and anti-IL-2 antibodies. The inventions aim to preferentially expand and activate T regulatory cells, making them suitable for large-scale production. Additionally, her patents include variant human IgG1 Fc molecules that maintain high stability despite lacking glycosylation at N297. The patents also describe linker peptides that are glycosylated when expressed in mammalian cells, along with methods for making and using these compositions.
Career Highlights
Christy Ann Thomson is currently employed at Amgen Inc., where she continues to innovate in the field of biotechnology. Her work has garnered attention for its potential to improve therapeutic strategies in immunology.
Collaborations
Thomson collaborates with notable colleagues, including Eric Alan Butz and Marc A Gavin. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Christy Ann Thomson is a trailblazer in immunology, with her patents reflecting her commitment to enhancing medical treatments. Her innovative work at Amgen Inc. continues to influence the future of immunotherapy.